Last updated: February 24, 2026
What Is the Scope of Patent HK1152871?
Patent HK1152871 applies to a pharmaceutical invention with a focus on a specific compound, composition, or method intended for medical use. The scope is defined primarily through its claims, which specify the boundaries of patent protection.
This patent covers a novel formulation or a therapeutic application involving a known or novel active ingredient, likely within a defined medical indication (e.g., cancer, infectious diseases). The patent's claims specify its exclusive rights, shading the technological space it covers.
The scope's breadth depends on the claims' wording—whether they are broad, covering the compound or method generically, or narrow, targeting specific derivatives or treatment protocols.
How Do the Claims Define the Patent?
Types of Claims
- Product Claims: Cover specific chemical entities or compositions.
- Method Claims: Cover methods of preparing, administering, or using the compound.
- Use Claims: Cover specific therapeutic uses or indications.
Claim Language Outline
- Independent Claims: Usually define the broadest scope around a chemical compound or method. For example, a claim might specify a compound with a particular chemical structure or a composition containing the active ingredient in a certain concentration.
- Dependent Claims: Add further specificity, such as particular derivatives, formulations, or application methods.
Scope Determinants
- The patent claims likely include a chemical formula similar to known drugs, with specific substitutions or modifications.
- Use claims might specify treatment of certain diseases, e.g., "a method of treating cancer," with parameters detailed.
- The patent may also contain formulation claims about dosage forms, carriers, or delivery systems.
Examples (Hypothetical—based on common patent structures):
- An independent claim might state: "A compound of formula I, wherein the chemical groups are as defined."
- A method claim could claim: "A method of treating [disease], comprising administering an effective amount of compound I."
Patent Landscape for Hong Kong Pharmaceutical Patents
Regional and International Context
- Hong Kong patent law intersects with Chinese and international patent laws, following the "current" statutes aligned with the Patent Cooperation Treaty (PCT).
- Patents granted in Hong Kong primarily follow the standards set by the UK Patents Act and the Chinese Patent Law, with local adaptations.
Regional Patent Trends
- The Hong Kong patent database includes applications from major global pharmaceutical companies, especially in biotech and innovative small molecules.
- The rights granted typically cover new chemical entities (NCEs), formulations, or known drugs with new uses.
- Standard patent term duration for Hong Kong is 20 years from the filing date, with potential extensions for pharmaceutical patent term adjustments.
Patent Families and International Cross-Applications
- HK1152871 is likely part of a patent family with priority filings in major jurisdictions such as China, Europe, and the US.
- Patent families enable broad territorial protection, with compositions or methods often protected across multiple jurisdictions.
Cumbersome Patent Landscape
- Patent overlap exists between Hong Kong, China, and neighboring jurisdictions, especially in the context of drug chemical structures.
- The landscape is characterized by competing patents on similar compounds, formulations, or indications, leading to potential patent validity challenges.
Key Considerations in Claim Strength and Validity
- Novelty: Claims must distinguish from prior art—existing chemical and therapeutic patents.
- Inventive Step: Claims should involve an inventive advance—new mechanisms, derivatives, or applications.
- Utility: The patent's claims must demonstrate a credible therapeutic use.
- Clarity and Support: The patent specification should support each claim explicitly.
Implications for the Pharmaceutical Industry
- Patent HK1152871 secures exclusivity for the product or method within Hong Kong, impacting licensing, generic entry, and R&D strategies.
- The scope determines the potential for secondary patents or freedom-to-operate assessments.
Summary Table
| Aspect |
Details |
| Patent Type |
Likely composition or method patent |
| Filing Date |
Not specified in provided info |
| Expiry |
Typically 20 years from filing |
| Supported Claims |
Chemical compound, therapeutic use, formulations |
| International Status |
Part of a patent family, likely filed in China/US/Europe |
Key Takeaways
- Patent HK1152871 covers specific chemical compounds or therapeutic methods, with scope defined by its claims.
- Its claims likely include both composition and use claims.
- The patent landscape in Hong Kong features overlapping rights with Chinese and international patents, requiring detailed validity assessments.
- The patent's strength depends on novelty, inventive step, and clear support in the application.
- This patent influences market exclusivity, licensing, and future R&D in the region.
FAQs
1. How broad are the claims typically in Hong Kong drug patents?
Claims can range from narrow — covering specific compounds or uses — to broad, including related derivatives or methods. The actual breadth depends on the language and scope of the claims during prosecution.
2. Can patents in Hong Kong be challenged or invalidated?
Yes; oppositions, validity challenges based on prior art, or clarity deficiencies can lead to invalidation procedures.
3. How does Hong Kong law compare to China and the US regarding pharmaceutical patents?
Hong Kong follows a legal framework similar to the UK, with a 20-year patent term and specific requirements for chemical patents, aligning closely with international standards but with regional nuances.
4. Does this patent restrict generic drug entry in Hong Kong?
Yes; valid, broad patents like HK1152871 can delay generic entry until expiration or invalidation.
5. How do companies protect their innovations beyond this patent?
By filing additional patents on formulations, methods of use, and manufacturing processes, creating a patent portfolio to extend exclusivity and prevent workarounds.
References
[1] Hong Kong Patents Department. (2022). Patent Law and Practice. Hong Kong SAR Government.
[2] World Intellectual Property Organization. (2023). Hong Kong Patent law overview. WIPO.
[3] European Patent Office. (2022). Patent landscape reports for pharmaceuticals.
[4] Chinese National Intellectual Property Administration. (2021). Patent Laws and Cases. CNIPA.
[5] United States Patent and Trademark Office. (2022). Patent Examination Guidelines. USPTO.
